BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16947020)

  • 1. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy.
    Stott B; Korbelik M
    Cancer Immunol Immunother; 2007 May; 56(5):649-58. PubMed ID: 16947020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of complement proteins on cells treated by photodynamic therapy in vitro.
    Cecic I; Korbelik M
    J Environ Pathol Toxicol Oncol; 2006; 25(1-2):189-203. PubMed ID: 16566717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB.
    Korbelik M
    Cancer Lett; 2009 Aug; 281(2):232-8. PubMed ID: 19328626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones.
    Merchant S; Huang N; Korbelik M
    Int Immunopharmacol; 2010 Dec; 10(12):1595-601. PubMed ID: 20933626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy.
    Cecic I; Serrano K; Gyongyossy-Issa M; Korbelik M
    Cancer Lett; 2005 Jul; 225(2):215-23. PubMed ID: 15978326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy.
    Merchant S; Korbelik M
    Cell Stress Chaperones; 2011 Mar; 16(2):153-62. PubMed ID: 20865355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
    Cecic I; Stott B; Korbelik M
    Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
    Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
    Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response.
    Korbelik M; Sun J; Cecic I
    Cancer Res; 2005 Feb; 65(3):1018-26. PubMed ID: 15705903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic and hypoxic induction of the complement factor C9 in cultured human retinal pigment epithelial cells: Regulation of VEGF and NLRP3 expression.
    Hollborn M; Ackmann C; Kuhrt H; Doktor F; Kohen L; Wiedemann P; Bringmann A
    Mol Vis; 2018; 24():518-535. PubMed ID: 30090015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy-generated vaccine for cancer therapy.
    Korbelik M; Sun J
    Cancer Immunol Immunother; 2006 Aug; 55(8):900-9. PubMed ID: 16215717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
    Cecic I; Parkins CS; Korbelik M
    Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolutionary analysis on complement genes reveals that fishes C3 and C9 experience different evolutionary patterns.
    Wang S; Wang R; Xu T
    Fish Shellfish Immunol; 2013 Dec; 35(6):2040-5. PubMed ID: 24184007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1.
    Merchant S; Korbelik M
    Immunobiology; 2013 Jun; 218(6):869-74. PubMed ID: 23182717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.
    Korbelik M; Zhang W; Merchant S
    Cancer Immunol Immunother; 2011 Oct; 60(10):1431-7. PubMed ID: 21644033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dying cells program their expedient disposal: serum amyloid P component upregulation in vivo and in vitro induced by photodynamic therapy of cancer.
    Merchant S; Sun J; Korbelik M
    Photochem Photobiol Sci; 2007 Dec; 6(12):1284-9. PubMed ID: 18046483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.
    Usuda J; Okunaka T; Furukawa K; Tsuchida T; Kuroiwa Y; Ohe Y; Saijo N; Nishio K; Konaka C; Kato H
    Int J Cancer; 2001 Aug; 93(4):475-80. PubMed ID: 11477550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
    Korbelik M; Cecic I
    J Photochem Photobiol B; 2008 Oct; 93(1):53-9. PubMed ID: 18715798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surfaces of the parasitic nematodes Trichinella spiralis and Toxocara canis differ in the binding of post-C3 components of human complement by the alternative pathway.
    Kennedy MW; Kuo YM
    Parasite Immunol; 1988 Jul; 10(4):459-63. PubMed ID: 2971916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.
    Yasojima K; Kilgore KS; Washington RA; Lucchesi BR; McGeer PL
    Circ Res; 1998 Jun; 82(11):1224-30. PubMed ID: 9633921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.